Medical Device

Melodi Health Secures $10.75M in Series A Funding; Enrolls First Patient in Pivotal Breast Reconstruction Trial

Melodi Health, a medical device company based in Minneapolis, announced two significant milestones last week. The company successfully closed a $10.75 million oversubscribed Series A funding round and launched the “ARIA” investigational device exemption (IDE) trial, designed to improve outcomes for women undergoing breast reconstruction following mastectomy. The funds raised will support ongoing clinical activities and further product development. Melodi Health, founded…

Corina Intrauterine Drug-Eluting System Receives Approval in China for Treating Intrauterine Adhesions

Shanghai-based Yipurun Biotech (YPR) has announced the approval of its Corina Intrauterine Drug-Eluting System (“Corina”) in China. This device is set to advance the treatment of patients with moderate-to-severe intrauterine adhesions (IUA) who undergo transcervical resection of adhesions (TCRA). The approval was granted based on a randomized controlled clinical trial that demonstrated Corina’s superior efficacy compared to the current standard-of-care treatments. Intrauterine…

Medtech Company Cairn Surgical Secures $4.5M to Advance Breast Conserving Surgery

Cairn Surgical, a medtech company focused on enhancing the precision of breast cancer surgeries, has successfully closed $4.5 million in Series A2 financing led by Morningside Ventures. The newly acquired funds will be directed towards completing the pivotal U.S. trial of Cairn Surgical’s Breast Cancer Locator (BCL™) System, a novel technology designed to significantly enhance the accuracy of breast-conserving surgeries, commonly known…

Medtech Startup Bone Index Secures Funding and Strategic Partnership to Expand Bone Health Diagnostics

Medtech company Bone Index has announced the successful close of its latest financing round and a new strategic partnership with Lynx Financial. This collaboration is set to enhance Bone Index’s distribution and service capabilities across North America and the Asia Pacific regions, allowing the company to meet the increasing demand for its bone health diagnostic solutions in these key markets. The funding,…

GE HealthCare and UC San Diego Collaborate to Advance Women’s Pelvic Imaging

GE HealthCare has announced a new collaboration with the University of California San Diego School of Medicine to enhance imaging techniques for diagnosing and managing female pelvic diseases, such as endometriosis and ovarian cancer. This partnership, which will be conducted through the Center for Translational Imaging and Precision Medicine (CTIPM) at UC San Diego, aims to develop advanced magnetic resonance imaging (MRI)…

Materna Medical Publishes Promising EASE Pilot Study Results for Pelvic Floor Dilator Use During Vaginal Delivery

Materna Medical has announced the publication of clinical results in the International Urogynecology Journal. The study, titled “Effect of an intrapartum pelvic dilator device on levator ani muscle avulsion during primiparous vaginal delivery: A pilot randomized controlled trial,” highlights the safety and effectiveness of Materna’s Prep Device in reducing childbirth-related pelvic floor injuries in first-time mothers. The study reports that the use…

Noze Secures $5M Investment from Gates Foundation for Breath-based Disease Detection Technology

Canadian-based Noze, a company working on breath-based diagnostics, has secured a $5 million equity investment from the Bill & Melinda Gates Foundation. This investment anchors a new funding round for the breath-based diagnostics startup. The funding follows two previous grants from the foundation, bringing its total contribution to $6.8 million. The funding will support further development of Noze’s disease detection platform for…

Hologic Completes $310M Acquisition of Endomag, a Developer of Breast Cancer Surgery Technologies

Medtech company Hologic has finalized its previously announced acquisition of Endomag, a UK-based developer of breast cancer surgery technologies, for approximately $310 million. Erik Anderson, President of Breast and Skeletal Health Solutions at Hologic noted: “We are thrilled to complete the acquisition of Endomag and are looking forward to working with our new colleagues to increase access to their innovative technologies, which…